Operating
Net Income
Vertex Pharmaceuticals Net Income decreased by 13.4% to $1.03B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 59.6%, from $646.30M to $1.03B. Over 3 years (FY 2021 to FY 2025), Net Income shows an upward trend with a 19.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase indicates higher profitability and operational success, while a decrease may signal rising costs or declining sales.
Detailed definition
Net income represents the total profit of the company after all operating expenses, taxes, and interest have been deduct...
Peer comparison
Standard across all public companies, though margins vary significantly by industry sector.
Metric ID:
net_income_cfHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $67.00M | $851.90M | $770.10M | $762.10M | $810.50M | $930.50M | $818.90M | $699.80M | $915.70M | $1.04B | $968.80M | $1.10B | -$3.59B | $1.05B | $646.30M | $1.03B | $1.08B | $1.19B | $1.03B |
| QoQ Change | — | >999% | -9.6% | -1.0% | +6.4% | +14.8% | -12.0% | -14.5% | +30.9% | +13.1% | -6.4% | +13.5% | -426.8% | +129.1% | -38.2% | +59.8% | +4.8% | +10.0% | -13.4% |
| YoY Change | — | — | — | — | >999% | +9.2% | +6.3% | -8.2% | +13.0% | +11.3% | +18.3% | +57.1% | -492.4% | +1.0% | -41.2% | +128.7% | +3.6% | — | +59.6% |
Range-$3.59B – $1.19B
CAGR+83.6%
Avg YoY Growth+62.6%
Median YoY Growth+10.2%
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Pharmaceuticals | $646.30M | $1.03B | $1.08B | $1.19B | $1.03B |
| Total | $646.30M | $1.03B | $1.08B | $1.19B | $1.03B |
Net Income at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's net income?
- Vertex Pharmaceuticals (VRTX) reported net income of $1.03B in Q1 2026.
- How has Vertex Pharmaceuticals's net income changed year-over-year?
- Vertex Pharmaceuticals's net income increased by 59.6% year-over-year, from $646.30M to $1.03B.
- What is the long-term trend for Vertex Pharmaceuticals's net income?
- Over 3 years (2021 to 2025), Vertex Pharmaceuticals's net income has grown at a 19.1% compound annual growth rate (CAGR), from $2.34B to $3.95B.
- What does net income mean?
- The total profit a company earns after all expenses and taxes are paid.